Dianthus Therapeutics | MGTA - Market Capitalization


Dianthus Therapeutics reported $2.93B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Celltrion KRW 37.87T 35.44T Jul/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 2.71B 1.87B Jul/2026
Divis Laboratories Ltd INR 1.58T 118.27B Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 136.51M 115.96M Jul/2026
Organon & Co USD 3.47B 1.9B Jul/2026
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pharma Mar EUR 1.57B 225M Mar/2026
Qiagen NV USD 8.27B 1.62B Mar/2026
Revvity USD 9.94B 1.03B Mar/2026
Sartorius EUR 14.25B 2.16B Mar/2026
Tectonic Therapeutic USD 510M 70M Jul/2026
Viatris USD 15.73B 1.39B Mar/2026
Xeris Pharmaceuticals USD 1.11B 112M Jul/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025